Cargando…
Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
The adenosine pathway is an exciting new target in the field of cancer immunotherapy. CD73 is the main producer of extracellular adenosine. Non-small cell lung cancer (NSCLC) has one of the highest CD73 expression signatures among all cancer types and the presence of common oncogenic drivers of NSCL...
Autores principales: | Kowash, Ryan R., Akbay, Esra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079876/ https://www.ncbi.nlm.nih.gov/pubmed/37033953 http://dx.doi.org/10.3389/fimmu.2023.1130358 |
Ejemplares similares
-
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation
por: Roberts, Veena, et al.
Publicado: (2014) -
Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
por: de Leve, Simone, et al.
Publicado: (2019) -
Editorial: Cancer cell-intrinsic and -extrinsic factors affecting tumor immune evasion
por: Sun, Jiazheng, et al.
Publicado: (2023) -
Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors
por: Chambers, Andrea M, et al.
Publicado: (2022) -
SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC
por: Hasmim, Meriem, et al.
Publicado: (2022)